CD81 and hepatocellular carcinoma: The tetraspanin CD81 has been identified as interaction partner of the HCV envelope glycoprotein E2 [46] and anti-CD81 mAbs, as well as a recombinant, soluble form of the large extracellular domain of CD81 inhibited the entry of HCV into hepatoma cell lines [47], [48].